Trade CMPX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Compass Therapeutics, Inc. (CMPX) is trading at US$2.48, down 1.79% today as of Aug 28, 12:22 EDT. The company has a market capitalisation of US$432.21M. Over the past 52 weeks, CMPX has traded between US$1.61 and US$6.88. On Syfe you can trade CMPX with $0 commission and add it to your watchlist.
| Previous close | US$2.52 |
|---|---|
| Market cap | US$432.21M |
| 52-week range | US$1.61 – US$6.88 |
| Volume | 1.69M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.
Year: 2020
Raymond James Downgrades Compass Therapeutics to Market Perform From Outperform
Apr 28, 11:38 AM · MT Newswires
Wedbush Lowers Compass Therapeutics Price Target to $5 From $8, Maintains Outperform Rating
Apr 27, 2:58 PM · MT Newswires
Compass Therapeutics Tovecimig Study Falls Short on Overall Survival Endpoint in Biliary Tract Cancer; Shares Fall Pre-Bell
Apr 27, 1:25 PM · MT Newswires
Top Premarket Decliners
Apr 27, 12:17 PM · MT Newswires
Compass Therapeutics' Q4 Net Loss Narrows
Mar 5, 12:55 PM · MT Newswires
Compass Therapeutics, Inc. (CMPX) stock is trading at US$2.48, -1.79% from the previous close of US$2.52.
The market cap for Compass Therapeutics, Inc. (CMPX) stock is approximately US$432.21M.
The 52-week high for Compass Therapeutics, Inc. (CMPX) stock is US$6.88.
The 52-week low for Compass Therapeutics, Inc. (CMPX) stock is US$1.61.
Compass Therapeutics, Inc. (CMPX) does not currently pay a dividend.
Stay on top of CMPX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
